Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

NCT06469424 is registered in ClinicalTrials.gov with Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa as lead sponsor.

NCT NCT06469424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
Lead sponsor
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Phase
Observational
Overall status
Unknown status
Start date
January 11, 2024
Completion date
March 31, 2026
Enrollment
104 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis